PDE7A-IN-1
PDE7A-IN-1 (Compound 26) is a potent and orally bioavailable PDE7A inhibitor (IC50 = 3.7 nM) . Its mechanism of sclerostin inhibition promotes increased bone mineral density, supporting its use in preclinical research for osteoporosis and other bone metabolic disorders in both cellular and animal models.
Product Specifications
Field of Research
Metabolism Research, Signal Transduction
Molecular Formula
C25H26ClN5O2
Molecular Weight
463.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
201-12-0028 96 Tests
Human soluble receptor for advanced glycation end products (sRAGE) ELISA Kit
Sign In for Pricing
View Details 
